Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence.
Arnaud Gregoire L'HuillierSabrina PaganoStephanie BaggioBenjamin MeyerDiego O AndreyMayssam NehmeIdris GuessousChristiane S EberhardtAngela HuttnerKlara M Posfay-BarbeSabine YerlyClaire-Anne SiegristLaurent KaiserNicolas VuilleumierPublished in: European journal of clinical investigation (2022)
COVID-19 induces a marked though transient AAA1 response, independently predicting one-year persistence of respiratory symptoms. By increasing IFN-α response, AAA1 may contribute to persistent symptoms. If and how AAA1 levels assessment could be of use for COVID-19 risk stratification remains to be determined.